首页> 外文OA文献 >P103 Minimal Clinically Important Difference (MCID) for the Ulcerative Colitis Patient-Reported Outcomes Signs and Symptoms (UC-PRO/SS) Tool

【2h】

P103 Minimal Clinically Important Difference (MCID) for the Ulcerative Colitis Patient-Reported Outcomes Signs and Symptoms (UC-PRO/SS) Tool

机译：P103最小临床上重要差异（MCID）用于溃疡性结肠炎患者报告的结果标志和症状（UC-PRO / SS）工具

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
J Pulley; D Galloway; Y Oh; J Devine; H Petrek; A Khavarian; A Matsui;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Development and validation of the Ulcerative Colitis patient-reported outcomes signs and symptoms (UC-pro/SS) diary [J] . Peter D. R. Higgins, Gale Harding, Dennis A. Revicki, Journal of Patient-Reported Outcomes . 2018,第1期

机译：溃疡性结肠炎患者报告的结局症状和体征（UC-pro / SS）日记的开发和验证
2. Understanding the Minimal Clinically Important Difference (MCID) of Patient-Reported Outcome Measures [J] . Sedaghat Ahmad R. Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery . 2019,第4期

机译：了解患者报告的结果措施的最小临床重要差异（MCID）
3. Crohn’s disease and ulcerative colitis patient-reported outcomes signs and symptoms for the remote management of inflammatory bowel disease during the COVID-19 pandemic [J] . Pinto Sergio, Loddo Erica, Paba Salvatore, Journal of Patient-Reported Outcomes . 2021,第1期

机译：克罗恩病和溃疡性结肠炎患者报告的结果征兆和症状在Covid-19大流行期间炎症性肠病的远程管理
4. Association between Local (Udder) Clinical Signs and Important Outcomes of Clinical Mastitis Episodes in Dairy Cattle [C] . J.R. Wenz, R. Elia, K. Whitman, Annual Conference of American Association of Bovine Practitioners . 2005

机译：地方（乳房）临床症状与乳房牛临床乳腺炎发作的重要成果
5. Long-Term Outcomes of Immunosuppression-Na?ve Steroid Responders following Hospitalization for Acute Severe Ulcerative Colitis [D] . Vedamurthy, Amar. 2018

机译：免疫抑制-NA've类固醇响应者的长期结果，治疗急性严重溃疡性结肠炎
6. Development and validation of the Ulcerative Colitis patient-reported outcomes signs and symptoms (UC-pro/SS) diary [O] . Peter D. R. Higgins, Gale Harding, Dennis A. Revicki, 2018

机译：溃疡性结肠炎患者报告的结局症状和体征（UC-pro / SS）日记的编制和验证
7. P224 Responder definitions for the ulcerative colitis Patient-Reported Outcomes Signs and Symptoms (UC-PRO/SS) tool using patients with ulcerative colitis treated with etrolizumab [O] . P Higgins, A Matsui, K DeBusk, 2019

机译：P224抑制性结肠炎患者报告的结果的定义，据报道的结果迹象和症状（UC-Pro / SS）工具使用患者用eTrolizub处理的溃疡性结肠炎患者

P103 Minimal Clinically Important Difference (MCID) for the Ulcerative Colitis Patient-Reported Outcomes Signs and Symptoms (UC-PRO/SS) Tool

著录项

引文网络

相似文献

相关主题

期刊订阅